New drug shows promise against dangerous virus in kidney transplants
NCT ID NCT05769582
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 26 times
Summary
This study tested a drug called AntiBKV in 95 kidney transplant patients who had a BKV infection. The goal was to see if it could safely lower the virus levels and prevent kidney damage. Patients received four doses of the drug or a placebo over several weeks, with regular check-ups and biopsies to monitor results.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BK VIREMIA; BKV DNAEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cedars-Sinai Medical Center
Los Angeles, California, 90048, United States
-
Cleveland Clinic
Cleveland, Ohio, 44195, United States
-
Hartford Hospital
Hartford, Connecticut, 06105, United States
-
Harvard Medical School
Boston, Massachusetts, 02215, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
Mayo Clinic
Phoenix, Arizona, 85054, United States
-
Mayo Clinic Transplant Center
Jacksonville, Florida, 32224, United States
-
MedStar Georgetown University Hospital
Washington D.C., District of Columbia, 20007, United States
-
Metrolina Nephrology Associates (MNA), PA
Charlotte, North Carolina, 28207, United States
-
New York Presbyterian Hospital - Weill Cornell Medical Center
New York, New York, 10065, United States
-
Ohio State University
Columbus, Ohio, 43210, United States
-
Saint Barnabas Medical Center
Livingston, New Jersey, 07039, United States
-
UT Southwestern
Dallas, Texas, 75390, United States
-
University of Alabama at Birmingham
Birmingham, Alabama, 35294, United States
-
University of California Davis
Sacramento, California, 95817, United States
-
University of California, Los Angeles
Los Angeles, California, 90024, United States
-
University of Kansas Medical Center
Kansas City, Kansas, 66160, United States
-
University of Maryland
Baltimore, Maryland, 21201, United States
-
University of Michigan Health System
Ann Arbor, Michigan, 48109, United States
-
University of Pennsylvania Hospital of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
-
University of Washington Medical Center
Seattle, Washington, 98195, United States
-
Washington University School of Medicine in St. Louis
St Louis, Missouri, 63110, United States
-
Yale University School of Medicine
New Haven, Connecticut, 06520, United States
Conditions
Explore the condition pages connected to this study.